Chiang, Anne C
자료유형 | 단행본 |
---|---|
개인저자 | Chiang, Anne C.,editor. Herbst, Roy S.,editor. |
단체저자명 | SpringerLink (Online service). |
서명/저자사항 | Lung Cancer [electronic resource] : New Understandings and Therapies / edited by Anne C. Chiang, Roy S. Herbst. |
판사항 | 1st ed. 2021. |
형태사항 | VI, 264 p. 17 illus., 16 illus. in color:online resource. |
총서사항 | Current Cancer Research=2199-2592 |
총서부출표목 | Current Cancer Research, |
기본자료 저록 | Springer Nature eBook |
기타형태 저록 | Printed edition:9783030740276Printed edition:9783030740290Printed edition:9783030740306 |
ISBN | 9783030740283 |
기타표준부호 | 10.1007/978-3-030-74028-3 |
내용주기 | Tumor Microenvironment: Immune Effector and Suppressor Imbalance -- Biomarkers: is tumor mutational burden the new prognostic grail? -- Liquid biopsies: new technology and evidence -- Osimertinib in EGFR-Mutant Non-Small Cell Lung Carcinoma: Clinical Activity and Mechanisms of Resistance -- What can we learn from acquired resistance? -- Management of Brain Metastases -- Spectrum and Management of Immune Related Adverse Events Due to Immune Checkpoint Inhibitors -- Therapeutic Advances in Small Cell Lung Cancer Management -- Small Cell Lung Cancer: Biology Advances -- Immunotherapy and Radiotherapy: New Strategies -- Ultimate Precision: Targeting Cancer but not Normal Self-Replication -- Index. |
요약 | Lung cancer has seen a paradigm shift in disease treatment over the past few years, with major changes in the therapeutic drugs now available as well as in the overall management approach. For targeted and immunotherapeutic approaches, understanding the biology of acquired resistance is a key strategy that has yielded productive advances in the subsequent treatment. Future advances also include incorporating biomarker data obtained from solid and liquid biopsies, as well as combination of immunotherapy with radiotherapy and in special populations such patients with CNS involvement. |
일반주제명 | Medicine—Research. Biology—Research. Internal medicine. Biomedical Research. Biomedical Research. Internal Medicine. |
바로가기 | URL |